CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $246,000 | +219.5% | 76,978 | +316.4% | 0.00% | – |
Q4 2021 | $77,000 | -56.5% | 18,487 | -15.2% | 0.00% | – |
Q3 2021 | $177,000 | +60.9% | 21,800 | +50.1% | 0.00% | – |
Q2 2021 | $110,000 | -19.7% | 14,521 | -8.2% | 0.00% | – |
Q1 2021 | $137,000 | +9.6% | 15,816 | +0.6% | 0.00% | – |
Q4 2020 | $125,000 | +2.5% | 15,716 | +3.0% | 0.00% | – |
Q3 2020 | $122,000 | -20.3% | 15,257 | -1.0% | 0.00% | – |
Q2 2020 | $153,000 | +30.8% | 15,410 | +1.4% | 0.00% | – |
Q1 2020 | $117,000 | +200.0% | 15,191 | +48.1% | 0.00% | – |
Q4 2019 | $39,000 | – | 10,255 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 675,000 | $918,000 | 1.02% |
Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |